5 employees
GPx is a digital therapeutics company that revolutionizes remote chronic disease management with bloodless blood tests.
2020
$3.3M
from 2 investors over 2 rounds
General Prognostics (GPx) raised undisclosed on June 20, 2023
Investors: PharmStars
General Prognostics (GPx) raised $3.3M on September 30, 2022
Investors: D4V (Design for Ventures)